bupropion for obesity
Selected indexed studies
- Medications for Obesity: A Review. (JAMA, 2024) [PMID:39037780]
- Naltrexone/bupropion for obesity. (Drug Ther Bull, 2017) [PMID:29117992]
- Obesity Management in Adults: A Review. (JAMA, 2023) [PMID:38015216]
_Worker-drafted node — pending editorial review._
Connections
bupropion for obesity is a side effect of
Sources
- Naltrexone/bupropion for obesity. (2017) pubmed
- Obesity Management in Adults: A Review. (2023) pubmed
- Drugs for Treating Obesity. (2022) pubmed
- Medications for Obesity: A Review. (2024) pubmed
- AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity. (2022) pubmed
- Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials. (2024) pubmed
- Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis. (2016) pubmed
- Pharmacotherapy for Obesity: Recent Updates. (2025) pubmed
- Naltrexone/bupropion for binge-eating disorder: A randomized, double-blind, placebo-controlled trial. (2023) pubmed
- Diets and drugs for weight loss and health in obesity - An update. (2021) pubmed